Epigenetic Reprogramming in Relapse AML
Clinical trial NCT02412475 · TERMINATED
Trial details
- NCT number
- NCT02412475
- Sponsor
- Michael Burke
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-21
- Primary completion
- 2017-06-21
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.